Abreos Biosciences and LifeAssays® AB form a jointly owned company and enter into associated license agreements. The new company is targeting revenue as early as Q1 2020
Abreos Biosciences ("Abreos") and LifeAssays have formed a jointly owned company in line with the Letter of Intent that was signed and published on July 26, 2019 ). LifeAssay's wholly owned subsidiary Magnasense Technologies Oy ("Magnasense"), Abreos and “NewCo” have also entered